Long term survival with thoracoscopic versus open lobectomy: propensity matched comparative analysis using SEER-Medicare database
- PMID: 25277994
- PMCID: PMC4183188
- DOI: 10.1136/bmj.g5575
Long term survival with thoracoscopic versus open lobectomy: propensity matched comparative analysis using SEER-Medicare database
Abstract
Objective: To compare long term survival after minimally invasive lobectomy and thoracotomy lobectomy.
Design: Propensity matched analysis.
Setting: Surveillance, Epidemiology and End Results (SEER)-Medicare database.
Participants: All patients with lung cancer from 2007 to 2009 undergoing lobectomy.
Main outcome measure: Influence of less invasive thoracoscopic surgery on overall survival, disease-free survival, and cancer specific survival.
Results: From 2007 to 2009, 6008 patients undergoing lobectomy were identified (n=4715 (78%) thoracotomy). The median age of the entire cohort was 74 (interquartile range 70-78) years. The median length of follow-up for entire group was 40 months. In a matched analysis of 1195 patients in each treatment category, no statistical differences in three year overall survival, disease-free survival, or cancer specific survival were found between the groups (overall survival: 70.6% v 68.1%, P=0.55; disease-free survival: 86.2% v 85.4%, P=0.46; cancer specific survival: 92% v 89.5%, P=0.05).
Conclusion: This propensity matched analysis showed that patients undergoing thoracoscopic lobectomy had similar overall, cancer specific, and disease-free survival compared with patients undergoing thoracotomy lobectomy. Thoracoscopic techniques do not seem to compromise these measures of outcome after lobectomy.
© Paul et al 2014.
Conflict of interest statement
Competing interest: All authors have completed the ICMJE uniform disclosure form at
Figures
Comment in
-
Minimally invasive thoracic surgery for early stage non-small cell lung cancer.BMJ. 2014 Oct 2;349:g5849. doi: 10.1136/bmj.g5849. BMJ. 2014. PMID: 25277995 No abstract available.
References
-
- National Institute for Health and Clinical Excellence. Lung cancer: the diagnosis and treatment of lung cancer. NICE, 2011.
-
- Treasure T, Russell C, Morton D, Macbeth F, Utley M. Surgical resection of lung cancer England: more operations but no trials to test their effectiveness. Thorax 2012;67:759-61. - PubMed
-
- Treasure T, Russell C, Morton D, Macbeth F, Utley M. Surgical resection of lung cancer in England: more operations but no trials to test their effectiveness. Thorax 2013;68:187-8. - PubMed
-
- Riaz SP, Luchtenborg M, Jack RH, Coupland VH, Linklater KM, Peake MD, et al. Variation in surgical resection for lung cancer in relation to survival: population-based study in England 2004-2006. Eur J Cancer 2012;48:54-60. - PubMed
-
- Riaz SP, Linklater KM, Page R, Peake MD, Moller H, Luchtenborg M. Recent trends in resection rates among non-small cell lung cancer patients in England. Thorax 2012;67:811-4. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical